Crispr Therapeutics

CRSP

Crispr Therapeutics has been a target of short sellers for a while. The current short interest of 19.41% is slightly below the average of the last 12 months (22.55%).

Short Interest Trend

Share Price

Total NSP

19.41%

+0.02%

vs. last month

Also interesting? All insider buys at Crispr Therapeutics

Found an error? Questions? Ideas?